LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Complete Blood Count Predicts Asymptomatic Preterm Birth

By LabMedica International staff writers
Posted on 08 Apr 2020
Print article
Image: The XN-350 hematology analyzer and blood cell counter (Photograph courtesy of Sysmex).
Image: The XN-350 hematology analyzer and blood cell counter (Photograph courtesy of Sysmex).
Preterm birth (PTB), defined as birth before 37 complete weeks of gestation, is a very serious obstetric problem worldwide. It affects 5% to 18% of all deliveries in the world and represents an enormous health care burden.

One of the most simple, economic, and routine clinical tests during pregnancy is the complete blood count (CBC). CBC and its derived parameters, including neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR), have been recognized as inflammatory markers for low‐grade inflammatory diseases in recent years.

Medical Laboratory Scientists at the Fujian Medical University (Fuzhou, China) and their colleagues included in a retrospective case‐control study, 15,387 total pregnant women for preterm deliveries and term deliveries between January and December 2017. After adjusting for these four clinical features with propensity score‐matched (PSM) analysis, a total of 105 and 210 pregnant women were retained in the study group and control group, respectively.

A Sysmex blood cell counter (Kobe, Japan) was used as a blood cell counting machine. The CBC parameters used in the study were as follows: WBC, white blood cell; Neu#, neutrophil count; Lym#, lymphocyte count; Mon#, monocyte count; HGB, hemoglobin; HCT, hematocrit; RDW, red cell distribution width; PLT, platelet count; MPV, mean platelet volume; PCT, plateletcrit; PDW, platelet distribution width; NLR, neutrophil‐to‐lymphocyte ratio; LMR, lymphocyte‐to‐monocyte ratio; PLR, platelet‐to‐lymphocyte ratio.

The team reported that NLR, MLR, PLR, PDW, and lymphocytes were statistically different between the two groups before PSM analysis. After PSM analysis, the statistical differences between the first four indicators (NLR, MLR, PLR, and PDW) were even more statistically significant, in addition, HGB and MPV, HCT also reached statistical differences between the two groups after PSM analysis. The mean values of NLR, PDW, MPV, HGB, HCT, PLR were significantly higher, and LMR and lymphocytes were significantly lower in preterm delivery group after PSM analysis.

The authors concluded that the combined marker of CBC parameters can supplement other markers to predict PTB about 10 weeks in advance. This combined marker had a very high negative predictive value for PTB. Therefore, in subjects with normal combined marker value, further screening tests for PTB may be eliminated unless clinical suspicion is high. The study was published on march 27, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Fujian Medical University
Sysmex


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Coagulation Analyzer
CS-2400

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.